|
101
|
Rozot V, Patrizia A, Vigano S, Mazza-Stalder J, Idrizi E, Day CL, Perreau M, Lazor-Blanchet C, Ohmiti K, Goletti D, Bart PA, Hanekom W, Scriba TJ, Nicod L, Pantaleo G, Harari A. Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis. Clin Infect Dis 2014; 60:432-7. [PMID: 25362202 PMCID: PMC4293395 DOI: 10.1093/cid/ciu795] [Citation(s) in RCA: 67] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
Immune-based assays are promising tools to help to formulate diagnosis of active tuberculosis. A multiparameter flow cytometry assay assessing T-cell responses specific to Mycobacterium tuberculosis and the combination of both CD4 and CD8 T-cell responses accurately discriminated between active tuberculosis and latent infection.
Collapse
Affiliation(s)
- Virginie Rozot
- Division of Immunology and Allergy, Lausanne University Hospital, Switzerland South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa
| | - Amelio Patrizia
- Division of Immunology and Allergy, Lausanne University Hospital, Switzerland
| | - Selena Vigano
- Division of Immunology and Allergy, Lausanne University Hospital, Switzerland
| | | | - Elita Idrizi
- Division of Immunology and Allergy, Lausanne University Hospital, Switzerland
| | - Cheryl L Day
- South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa
| | - Matthieu Perreau
- Division of Immunology and Allergy, Lausanne University Hospital, Switzerland
| | - Catherine Lazor-Blanchet
- Occupational Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland
| | - Khalid Ohmiti
- Division of Immunology and Allergy, Lausanne University Hospital, Switzerland
| | - Delia Goletti
- National Institute for Infectious Diseases, Rome, Italy
| | | | - Willem Hanekom
- South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa
| | - Thomas J Scriba
- South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa
| | | | - Giuseppe Pantaleo
- Division of Immunology and Allergy, Lausanne University Hospital, Switzerland Swiss Vaccine Research Institute, Lausanne, Switzerland
| | - Alexandre Harari
- Division of Immunology and Allergy, Lausanne University Hospital, Switzerland Swiss Vaccine Research Institute, Lausanne, Switzerland
| |
Collapse
|
|
102
|
Van Rie A, Moultrie H. Novel biomarkers for paediatric tuberculosis. THE LANCET. INFECTIOUS DISEASES 2014; 14:900-1. [PMID: 25185460 DOI: 10.1016/s1473-3099(14)70898-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- Annelies Van Rie
- University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7435, USA.
| | - Harry Moultrie
- Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa
| |
Collapse
|